CFDE Data Portal | Search FRMPD2B

	Label	Description
	FRMPD2B associations Collection (Entity type)	Associations for FRMPD2B_associations
	FRMPD2B associations.tsv File (Entity type)	A file from IDG as part of the Harmonizome project
	FRMPD2B Gene (Entity type)	ENSG00000293529 - FERM and PDZ domain containing 2B (pseudogene)
	GSE212330 azacitidine 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE208350 H-7 Huh-7 JHH-7 0 v 3 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 nicotinamide 5 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE159678 hydroxychloroquine 4 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE201309 matrine 1 v 8 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE233679 nicotinamide 5 v 13 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE226249 pirfenidone HL 0 v 6 human dn Gene Set (Entity type)	A Gene Set from LINCS

FRMPD2B associations

Associations for FRMPD2B_associations

FRMPD2B associations.tsv

A file from IDG as part of the Harmonizome project

FRMPD2B

ENSG00000293529 - FERM and PDZ domain containing 2B (pseudogene)

GSE212330 azacitidine 1 v 0 human dn

A Gene Set from LINCS

GSE208350 H-7 Huh-7 JHH-7 0 v 3 human up

A Gene Set from LINCS

GSE233679 nicotinamide 5 v 1 human dn

A Gene Set from LINCS

GSE159678 hydroxychloroquine 4 v 7 human dn

A Gene Set from LINCS

GSE201309 matrine 1 v 8 human dn

A Gene Set from LINCS

GSE233679 nicotinamide 5 v 13 human dn

A Gene Set from LINCS

GSE226249 pirfenidone HL 0 v 6 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.